FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002114788> ?p ?o ?g. }

• W2002114788 endingPage "13849" @default.
• W2002114788 startingPage "13839" @default.
• W2002114788 abstract "The integral endoplasmic reticulum (ER)-membrane protein VAP-B interacts with various lipid-transfer/binding proteins containing an FFAT motif through its N-terminal MSP domain. A genetic mutation within its MSP domain, P56S, was identified in familial forms of motor neuron diseases. This mutation induces the formation of insoluble VAP-B(P56S) protein aggregates by an unknown mechanism. In this study, we defined the structural requirements for VAP-B oligomerization and demonstrated their contribution for VAP-B(P56S) aggregation and neurotoxicity. We show that the oligomerization of VAP-B is mainly mediated by its coiled-coil domain and that the GXXXG dimerization motif within the transmembrane domain mediates transmembrane domains self-association but is insufficient to drive VAP-B oligomerization. We further show that the oligomerization of the wild-type VAP-B is independent of its MSP domain. However, we found that the P56S mutation induces conformational changes within the MSP domain and facilitates its propensity to aggregate by exposing hydrophobic patches to the solvent. These conformational changes have no direct effect on FFAT binding. Rather, they enhance VAP-B(P56S) oligomerization driven by the combined contributions of the coiled-coil and the transmembrane domains, thereby preventing accessibility to FFAT-binding site, facilitating the production of VAP-B(P56S)-insoluble aggregates and consequently its neurotoxicity. These results shed light on the mechanism by which VAP-B(P56S) aggregates are formed and induce familial motor neuron diseases. The integral endoplasmic reticulum (ER)-membrane protein VAP-B interacts with various lipid-transfer/binding proteins containing an FFAT motif through its N-terminal MSP domain. A genetic mutation within its MSP domain, P56S, was identified in familial forms of motor neuron diseases. This mutation induces the formation of insoluble VAP-B(P56S) protein aggregates by an unknown mechanism. In this study, we defined the structural requirements for VAP-B oligomerization and demonstrated their contribution for VAP-B(P56S) aggregation and neurotoxicity. We show that the oligomerization of VAP-B is mainly mediated by its coiled-coil domain and that the GXXXG dimerization motif within the transmembrane domain mediates transmembrane domains self-association but is insufficient to drive VAP-B oligomerization. We further show that the oligomerization of the wild-type VAP-B is independent of its MSP domain. However, we found that the P56S mutation induces conformational changes within the MSP domain and facilitates its propensity to aggregate by exposing hydrophobic patches to the solvent. These conformational changes have no direct effect on FFAT binding. Rather, they enhance VAP-B(P56S) oligomerization driven by the combined contributions of the coiled-coil and the transmembrane domains, thereby preventing accessibility to FFAT-binding site, facilitating the production of VAP-B(P56S)-insoluble aggregates and consequently its neurotoxicity. These results shed light on the mechanism by which VAP-B(P56S) aggregates are formed and induce familial motor neuron diseases." @default.
• W2002114788 created "2016-06-24" @default.
• W2002114788 creator A5007323717 @default.
• W2002114788 creator A5015402015 @default.
• W2002114788 creator A5029597229 @default.
• W2002114788 creator A5051953963 @default.
• W2002114788 creator A5063405568 @default.
• W2002114788 date "2010-04-01" @default.
• W2002114788 modified "2023-10-14" @default.
• W2002114788 title "Structural Requirements for VAP-B Oligomerization and Their Implication in Amyotrophic Lateral Sclerosis-associated VAP-B(P56S) Neurotoxicity" @default.
• W2002114788 cites W1521958691 @default.
• W2002114788 cites W1545244782 @default.
• W2002114788 cites W1562088891 @default.
• W2002114788 cites W1565076702 @default.
• W2002114788 cites W1917951968 @default.
• W2002114788 cites W1963798656 @default.
• W2002114788 cites W1964679889 @default.
• W2002114788 cites W1969787762 @default.
• W2002114788 cites W1971315869 @default.
• W2002114788 cites W1972065586 @default.
• W2002114788 cites W1993554801 @default.
• W2002114788 cites W1994373739 @default.
• W2002114788 cites W2001788248 @default.
• W2002114788 cites W2002559713 @default.
• W2002114788 cites W2011764708 @default.
• W2002114788 cites W2012859794 @default.
• W2002114788 cites W2013830076 @default.
• W2002114788 cites W2015061134 @default.
• W2002114788 cites W2016162029 @default.
• W2002114788 cites W2019011921 @default.
• W2002114788 cites W2024984804 @default.
• W2002114788 cites W2025629415 @default.
• W2002114788 cites W2028129739 @default.
• W2002114788 cites W2029572675 @default.
• W2002114788 cites W2034476449 @default.
• W2002114788 cites W2040344798 @default.
• W2002114788 cites W2043921345 @default.
• W2002114788 cites W2045673635 @default.
• W2002114788 cites W2048443355 @default.
• W2002114788 cites W2049822037 @default.
• W2002114788 cites W2052586663 @default.
• W2002114788 cites W2057297382 @default.
• W2002114788 cites W2062197104 @default.
• W2002114788 cites W2062553162 @default.
• W2002114788 cites W2068808513 @default.
• W2002114788 cites W2071224136 @default.
• W2002114788 cites W2071921711 @default.
• W2002114788 cites W2090810860 @default.
• W2002114788 cites W2097880162 @default.
• W2002114788 cites W2099927195 @default.
• W2002114788 cites W2106178605 @default.
• W2002114788 cites W2108383442 @default.
• W2002114788 cites W2110551795 @default.
• W2002114788 cites W2111600486 @default.
• W2002114788 cites W2114918609 @default.
• W2002114788 cites W2122216266 @default.
• W2002114788 cites W2123136002 @default.
• W2002114788 cites W2128815118 @default.
• W2002114788 cites W2129426780 @default.
• W2002114788 cites W2155013883 @default.
• W2002114788 cites W2158787641 @default.
• W2002114788 cites W2161344604 @default.
• W2002114788 cites W2170376656 @default.
• W2002114788 cites W2319723556 @default.
• W2002114788 doi "https://doi.org/10.1074/jbc.m109.097345" @default.
• W2002114788 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2859547" @default.
• W2002114788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20207736" @default.
• W2002114788 hasPublicationYear "2010" @default.
• W2002114788 type Work @default.
• W2002114788 sameAs 2002114788 @default.
• W2002114788 citedByCount "66" @default.
• W2002114788 countsByYear W20021147882012 @default.
• W2002114788 countsByYear W20021147882013 @default.
• W2002114788 countsByYear W20021147882014 @default.
• W2002114788 countsByYear W20021147882015 @default.
• W2002114788 countsByYear W20021147882016 @default.
• W2002114788 countsByYear W20021147882017 @default.
• W2002114788 countsByYear W20021147882018 @default.
• W2002114788 countsByYear W20021147882019 @default.
• W2002114788 countsByYear W20021147882020 @default.
• W2002114788 countsByYear W20021147882021 @default.
• W2002114788 countsByYear W20021147882022 @default.
• W2002114788 countsByYear W20021147882023 @default.
• W2002114788 crossrefType "journal-article" @default.
• W2002114788 hasAuthorship W2002114788A5007323717 @default.
• W2002114788 hasAuthorship W2002114788A5015402015 @default.
• W2002114788 hasAuthorship W2002114788A5029597229 @default.
• W2002114788 hasAuthorship W2002114788A5051953963 @default.
• W2002114788 hasAuthorship W2002114788A5063405568 @default.
• W2002114788 hasBestOaLocation W20021147881 @default.
• W2002114788 hasConcept C104317684 @default.
• W2002114788 hasConcept C118892022 @default.
• W2002114788 hasConcept C12554922 @default.
• W2002114788 hasConcept C144647389 @default.
• W2002114788 hasConcept C158617107 @default.
• W2002114788 hasConcept C170493617 @default.
• W2002114788 hasConcept C178790620 @default.
• W2002114788 hasConcept C185592680 @default.

• next